{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "High-Sensitivity Cardiac Troponin T in Detecting Perioperative Myocardial Infarction: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Conducted as an ancillary study within the Vitamins in Nitrous Oxide trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "605 patients who had baseline and at least one postoperative hscTnT measurement. The study setting was a surgical environment."
      },
      "Intervention": {
        "score": 2,
        "evidence": "assessed the utility of a high-sensitivity cardiac troponin T (hscTnT) assay versus contemporary cardiac troponin I (cTnI)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study assessed the utility of a high-sensitivity cardiac troponin T (hscTnT) assay versus contemporary cardiac troponin I (cTnI) in identifying perioperative myocardial infarction (MI) following non-cardiac surgery."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was the incidence of myocardial injury and MI"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomisation and allocation concealment methods were not detailed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding of outcome assessors, patients, and clinicians was not specified."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "605 patients"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Of the 605 patients, 70 (12%) exhibited ECG changes indicative of myocardial ischemia."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Using contemporary cTnI, 82 patients (14%) were diagnosed with myocardial injury, with 31 (5.1%) confirmed as MI. The hscTnT assay identified 67 patients (11%) with MI, representing a twofold increase in detection."
      },
      "Harms": {
        "score": 0,
        "evidence": "Adverse events were not reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration and funding information were not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Trial registration and funding information were not provided."
      }
    },
    "total_score": 12,
    "max_score": 25
  },
  "model": "gpt-4o"
}